Simpson Thacher Represents J.P. Morgan and Bank of America in Connection with the Committed Financing of IHS Inc.’s Acquisition of R. L. Polk & Co./Carfax

Simpson Thacher is representing JPMorgan Chase Bank, N.A. as administrative agent and J.P. Morgan Securities LLC as lead arranger and bookrunner in connection with the $680 million committed financing for the $1.4 billion acquisition of R.L. Polk & Co. by IHS Inc. The acquisition is expected to be consummated later this year.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Jones Day Welcomes Dallas Health Care Transactions Partner Todd Kelly

Todd P. Kelly has joined the Dallas Office of global law firm Jones Day as a partner in the Health Care and Life Sciences practices, where his practice will focus on the representation of hospitals, health systems, medical groups, and other health care providers in connection with mergers and acquisitions, joint ventures, affiliations, and other complex transactional and regulatory matters. He was formerly a partner in the Dallas office of Norton Rose Fulbright.

More >>

Tags:  Jones Day | Dallas

Perkins Coie’s Chicago Office Bolsters New Personal Planning Practice

Perkins Coie is pleased to announce that Sandra K. Newman and Lucy K. Park have joined the firm’s Chicago office as part of Chicago’s newly-launched Personal Planning group. They were most recently partners at K & L Gates. The arrival of Newman and Park follows closely on the recent addition of Domingo Such, who joined Perkins Coie in late May. The three partners are spearheading Chicago’s Personal Planning practice. With the most recent hires, the firm has added 6 new partners and 11 attorneys overall to its Chicago office since January.

More >>

Tags:  Perkins Coie LLP

Milbank – US$ 12.5 Billion Financing for Sadara Integrated Chemicals Project

The second phase of the financing for the construction of Sadara Chemical Company’s integrated petrochemicals production complex in Jubail Industrial City II, Saudi Arabia was signed on 16 June, raising an aggregate of US$12.5 Billion. Sadara is a joint venture between The Dow Chemical Company and Saudi Arabian Oil Company. Milbank acted as international counsel to all of the lenders to the Project as well as to the joint lead managers of Sadara’s earlier US$2 billion Sukuk issuance (which was amongst the world’s largest project bonds).

More >>

Tags:  Milbank LLP

Jeffrey Blumenfeld Joins Lowenstein Sandler to Chair Antitrust Practice

Lowenstein Sandler LLP announced that Jeffrey Blumenfeld has joined the firm as chair of its Antitrust & Trade Regulation practice focusing on antitrust litigation and counseling. He also will be a member of Lowenstein’s Tech Group, a national leader in representing venture-backed technology companies, where he will actively counsel Lowenstein’s clients and their investors on competition issues facing emerging technology companies, particularly at the intersection of antitrust and intellectual property.

More >>

Tags:  Lowenstein Sandler LLP | New York

Cooley Advises Underwriters on Epizyme, Inc. Initial Public Offering

Cooley LLP announced today that it advised the underwriters on Epizyme, Inc.’s recent IPO. Epizyme, now trading on the NASDAQ Global Stock Market under the symbol “EPZM,” is a Massachusetts-based biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers.

More >>

Tags:  Cooley LLP | San Francisco

Travers Smith Acts on £1.54bn IPO of Partnership Assurance Group Plc

A tax and corporate team, led by tax partner Kathleen Russ and corporate partner Edmund Reed, have advised Partnership Assurance Group Plc (“PAG”) and its management team on matters relating to management shareholders and option holders in connection with the company’s listing on the main market of the London Stock Exchange on 12 June 2013 and an IPO involving the sale of shares by the management team and funds managed by Cinven.

More >>

Tags:  Travers Smith